Moleculin Biotech, Inc.
USD2.65
-0.92 (-25.77%)
CEO
Walter V. Klemp
IPO Date
2016-06-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.99
Prev. Close
$3.57
Day Low
$2.35
Day High
$3.15
52W Low
$1.79
52W High
$24.00
Market Cap
$0.01B
Volume
2.31M
| -0.3 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -114.2% | -77.9% | 0.02 | 3.86 | -0.9 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -55.6% | -50.5% | 0.01 | 9.46 | -1.0 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -20.1% | -18.9% | 0.00 | 20.02 | -3.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -97.0% | -59.5% | 0.02 | 5.89 | -2.7 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -84.8% | -52.3% | 0.02 | 3.78 | -2.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -83.2% | -60.6% | 0.00 | 2.06 | -2.3 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -57.3% | -50.3% | 0.00 | 3.75 | -3.5 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -26.2% | -24.0% | 0.02 | 3.88 | -5.7 |
| 0.6 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | 94.3% | -124.8% | -0.01 | 1.39 | -0.2 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | 106.6% | -35.4% | -0.06 | 1.15 | -0.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -15323.8% | -30.6% | 10.71 | 1.35 | -0.0 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -31.5% | -11.1% | 0.08 | 0.97 | -0.8 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -141.6% | -45.3% | 0.07 | 2.08 | -0.2 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -24.4% | -16.9% | 0.03 | 2.39 | -0.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -23.0% | -16.1% | 0.03 | 3.51 | -0.7 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -39.4% | -26.9% | 0.02 | 3.86 | -0.6 |